Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
King International InvestmentHKSE:00928 -4.85% Market Cap is HK$181.3 Mil as of Aug. 09, 2026. The stock has 5 warning signs investors should review. Among 217 Medical Diagnostics & Research companies, King International Investment ranks worse than 68.66% on this metric.
King International Investment's quarterly market cap
increased
from Mar. 2025 (HK$53.7 Mil) to Sep. 2025 (HK$212.8 Mil) but then
declined
from Sep. 2025 (HK$212.8 Mil) to Mar. 2026 (HK$140.6 Mil).
King International Investment's annual market cap
declined
from Mar. 2024 (HK$142.5 Mil) to Mar. 2025 (HK$53.7 Mil) but then
increased
from Mar. 2025 (HK$53.7 Mil) to Mar. 2026 (HK$140.6 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. King International Investment's Enterprise Value for Today is HK$182.8 Mil.
King International Investment (HKSE:00928) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
King International Investment Market Cap Related Terms
King International Investment Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:00928 vs TMO, DHR, IDXX: Market Cap Comparison
For the Diagnostics & Research subindustry, King International Investment's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
King International Investment Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, King International Investment's Market Cap distribution charts can be found below:
* The bar in red indicates where King International Investment's Market Cap falls into.
King International Investment Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
King International Investment (HKSE:00928) has a Market Cap of HK$181.3 Mil as of Aug. 09, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on King International Investment and its competitors. According to the industry distribution chart, King International Investment ranks #149 out of 217 companies in the Medical Diagnostics & Research industry, placing it in the top 68.7%.
Is King International Investment's Market Cap too high?
King International Investment's current Market Cap is HK$181.3 Mil. Based on the distribution chart, King International Investment ranks #149 out of 217 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint.
How does King International Investment's Market Cap compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, King International Investment ranks #149 out of 217 companies for Market Cap. This places King International Investment in the lower half of its industry. The industry median Market Cap is 59.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 59.35, based on 217 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on King International Investment and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 59.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. King International Investment's current Market Cap is HK$181.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is King International Investment stock overvalued right now?
Based on GuruFocus' analysis, King International Investment (HKSE:00928) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.04, compared to a current price of HK$0.10 — trading 145% above its estimated fair value. The current Market Cap is HK$181.3 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For King International Investment (HKSE:00928), the current Market Cap is HK$181.3 Mil as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
King International Investment Ltd is an investment holding company. Its operating segments include healthcare products and services, money lending, and liquor sales, with the majority of revenue generated from the liquor sales segment. The group provides genetic testing and develops domestic healthcare equipment services. Leveraging its strengths, the group integrates health data analysis software with healthcare equipment to offer new healthcare services and products. Geographically, it derives the majority of its revenue from the PRC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00928 has been successfully added to your 
